THE WORLD'S LEADING PROVIDER
OF ORALLY ADMINISTERED, SMALL-MOLECULE
DRUGS THAT TREAT DISEASES BY
TARGETING AND MODULATING RNA.
JUPITER, FL, April 30, 2013 – SMaRT Therapeutics, Inc., a leading biotechnology company focused on the development of small-molecule drugs that target and modulate RNA, announced the appointment of Dr. John H. Abeles to its Advisory Board.